Search
Spyre Therapeutics Inc
SYREAdd to Watchlist
88.340USD
+0.850+0.97%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
7.67BMarket Cap
LossP/E TTM
Spyre Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Spyre Therapeutics Inc is 9.17, ranking 51 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -34.53, which is -108.47% below the recent high of 2.92 and 0.00% above the recent low of -34.53.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
